ANGENOVO AS
Operating
Importere, eksportere, utvikle og selge kjemiske reagenser og
instrumenter for biologisk og medisinsk forskning, og levere
dataanalyse og konsulenttjenester.
Utvikle instrumenter for biologisk og medisinsk forskning.
Organization
- CEO
- YG
Yanwu Guo1983
- Chairman of the board
- YG
Yanwu Guo1983
- Years since formation
- 7 years
- since May 2, 2019
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 10,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2025
- 613,000
- NOK
- Annual total result 2025
- 162,760
- NOK
- Total equity 2025
- 328,888
- NOK
Last update: Sep 14, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
YG 1983 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
YG 1983 | Chairman | - |
CS 1980 | Board Member | - |
HH | Board Member | - |
AK | Board Member | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
GY 1983 | - | 100 % indirectly |
Last update: May 15, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 10,000 | 100 % |
Shares owned by the ANGENOVO AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
O Closed | NO0010779341 | 10,000 | < 0.01 % |
| Ordinary shares | 500 | < 0.01 % | |
| Ordinary shares | 12,026 | < 0.01 % |
Last update: Sep 25, 2026
Group structure
- Total operating income 2025: NOK 0Operating profit 2025: NOK -7,274Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 613,000 | 432,692 | 4,273,773 | 4,885,046 | 3,802,318 |
Annual Total Result | 162,760 | -129,812 | 18,615 | -17,251 | 174,721 |
Total assets | 463,687 | 337,198 | 450,905 | 500,399 | -567,404 |
Total liabilities | 134,799 | 171,070 | 154,965 | 223,074 | -861,981 |
Total equity | 328,888 | 166,128 | 295,940 | 277,326 | 294,577 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 613,000 | 432,692 | 4,273,773 | 4,885,046 | 3,802,318 |
Total operating costs | 440,660 | 540,517 | 4,236,252 | 4,902,354 | 3,580,577 |
Operating result | 172,340 | -107,825 | 37,521 | -17,308 | 221,741 |
Financial income/costs | -209 | -23,650 | -13,656 | -304 | 2,260 |
Profit before tax | 172,131 | -131,475 | 23,865 | -17,612 | 224,001 |
Total tax & extraordinary income/cost | 9,371 | -1,663 | 5,250 | -361 | 49,280 |
Annual Total Result | 162,760 | -129,812 | 18,615 | -17,251 | 174,721 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 100,492 | 77,020 | 30,000 | 30,000 | 0 |
Total current assets | 363,195 | 260,178 | 420,905 | 470,399 | -567,404 |
Total assets | 463,687 | 337,198 | 450,905 | 500,399 | -567,404 |
Short term debt | 134,641 | 171,070 | 154,965 | 223,074 | -861,981 |
Long term debt | 158 | 0 | 0 | 0 | 0 |
Total liabilities | 134,799 | 171,070 | 154,965 | 223,074 | -861,981 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 | 24,430 |
Retained earnings | 298,888 | 136,128 | 265,940 | 247,326 | 270,147 |
Total equity | 328,888 | 166,128 | 295,940 | 277,326 | 294,577 |
Total equity and liabilities | 463,687 | 337,198 | 450,905 | 500,400 | -567,404 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification